ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $7.44 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.